Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma

Lancet Oncol. 2019 Feb;20(2):e124. doi: 10.1016/S1470-2045(18)30577-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anilides / adverse effects*
  • Anilides / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Pneumothorax / chemically induced*
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Anilides
  • Pyridines
  • cabozantinib